Regulate Medicine by Cell Regeneration
mexico Considers Regulating Regenerative medicine Amid Public Health Concerns
Table of Contents
- mexico Considers Regulating Regenerative medicine Amid Public Health Concerns
- Mexico Considers Regulating Regenerative Medicine: Your Questions Answered
- What is Regenerative Medicine?
- What is the Current Situation in Mexico Regarding regenerative Medicine?
- Why is Mexico Considering Regulating Regenerative Medicine?
- What Areas of Regenerative Medicine Are Covered in the Proposed Reforms?
- How Does the Proposal Define Key Terms Like “Progenitor Cells”?
- What Requirements Will Health Establishments offering Regenerative Medicine Need to Meet?
- Who is Responsible for the Safety of Regenerative Medicine Procedures?
- Who Oversees the Procedures, and What Qualifications/Certifications are required?
- What is the Importance of Informed Consent in Regenerative Medicine?
- What is the Potential of Regenerative Medicine?
- How is Regenerative Medicine Related to Mexico’s Public Health Crisis?
- What are Mesenchymal Trunk Cells (CTM), and What are Their Potential Uses?
- Summary of Key Aspects of Mexico’s Proposed Regenerative Medicine Regulations
MEXICO CITY (AP) — Two members of the Morena party in the Chamber of Deputies, Fernando Jorge Castro Trenti and Pedro Mario Zenteno Santaella, have proposed reforms to the General Health Law to regulate regenerative medicine. the initiative aims to establish clear guidelines and oversight for cell-based therapies.
Defining Regenerative Medicine
The proposed reforms define regenerative medicine as medical interventions focused on restoring the function of tissues or organs. This includes the use of cells and their derivatives, tissue engineering, gene therapies, and related support systems.
Key Aspects of the Proposed Reforms
- Updated Definitions: The reforms incorporate current technical definitions of mesenchymal progenitor cells and their therapeutic potential.
- Scientific Criteria: The use of these cells would be regulated through established scientific criteria.
- Establishment Oversight: Control and evaluation of health establishments offering regenerative medicine therapies would be implemented.
- Professional Training: Specialized professional training in regenerative medicine would be promoted.
- Preventing Unauthorized Use: The reforms seek to prevent the unauthorized use of cell therapies lacking ethical or scientific validation.
Cell Definitions
The proposal clarifies the definition of progenitor cells, also known as truncal cells, as those capable of transforming into all types of blood cells, including white blood cells, red blood cells, and platelets. These cells are found in peripheral blood and bone marrow.
Non-hematopoietic mesenchymal trunk cells are defined as those obtained from sources such as adipose tissue, placental tissue, dental pulp, and umbilical cord, as well as other mesoderm of the connective tissue.
Requirements for Health Establishments
Under the proposed regulations, health establishments or non-hematopoietic mesenchymal trunk cell banks would be required to enter into agreements with specialized facilities. These facilities would focus on the cultivation, expansion, differentiation, and research of progenitor cells or non-hematopoietic mesenchymal trunks and must possess health authorization from competent health authorities.
Moreover, these establishments must adhere to official Mexican standards and applicable provisions to ensure the availability of cells.
Transplant Safety and Physician Responsibility
The arrangement of hematopoietic trunk cells and/or non-hematopoietic mesenchymal cells would be the responsibility of regenerative medicine establishments. These establishments would be accountable for the safety of transplants conducted for research or therapeutic purposes.
The attending physician, holding a professional card in longevity and certification from an institution accredited by the Ministry of Public Education and the general Directorate of Professions, would oversee the procedure. The physician must also be recognized by relevant laws.
According to the proposal,The transplant must be carried out under an informed consent that gives certainty,security and respect for the human rights of patients.
Regenerative Medicine’s Potential
The document, now under review by the Health Commission, highlights regenerative medicine as a promising area in contemporary clinical practice. It focuses on restoring cellular, tissue, and organic functions through advanced biotechnological therapies.
Addressing Public Health Crisis
The proposal notes that Mexico faces a public health crisis stemming from the high prevalence of chronic noncommunicable diseases, or ECNT, including type 2 diabetes, hypertension, obesity, and neurodegenerative diseases. According to 2023 data from INEGI, these diseases account for more than 77% of mortality causes in the country.
Mesenchymal Trunk Cells
Regenerative medicine offers advanced therapies based on cell and tissue regeneration, especially through the use of mesenchymal trunk cells, or CTM. These cells have shown favorable results in clinical studies for conditions such as acute myocardium infarctions, multiple sclerosis, Parkinson’s disease, osteoarthritis, and medullary lesions.
###
Mexico Considers Regulating Regenerative Medicine: Your Questions Answered
What is Regenerative Medicine?
Regenerative medicine is a field of medicine focused on restoring the function of damaged tissues or organs. It involves using various approaches,including cells and their derivatives,tissue engineering,gene therapies,and related support systems. The goal is to repair or replace damaged tissues, giving patients a better quality of life.
What is the Current Situation in Mexico Regarding regenerative Medicine?
Two members of the Morena party in the Chamber of Deputies, Fernando Jorge Castro Trenti and Pedro Mario Zenteno Santaella, have proposed reforms to Mexico’s General Health law.These reforms aim to regulate regenerative medicine and establish clear guidelines and oversight for cell-based therapies. the proposal is currently under review by the Health Commission.
Why is Mexico Considering Regulating Regenerative Medicine?
Mexico is taking steps to regulate regenerative medicine due to several factors. First, there’s a growing interest in cell-based therapies. However, the goverment is also addressing public health concerns about the safety and efficacy of these treatments. The proposed reforms aim to prevent the unauthorized use of cell therapies lacking ethical or scientific validation.
What Areas of Regenerative Medicine Are Covered in the Proposed Reforms?
The proposed reforms in Mexico’s General Health Law cover several key areas:
Definitions: Updating technical definitions of terms like ”mesenchymal progenitor cells” and their therapeutic potential.
Scientific Criteria: Regulating the use of cells thru established scientific criteria to ensure safety and efficacy.
Establishment Oversight: Implementing control and evaluation of health establishments offering regenerative medicine therapies.
Professional Training: Promoting specialized professional training in regenerative medicine for healthcare providers.
Preventing Unauthorized use: Preventing the use of cell therapies without proper ethical and scientific validation.
How Does the Proposal Define Key Terms Like “Progenitor Cells”?
The proposal clarifies the definition of progenitor cells as “truncal cells.” These are cells that can transform into all blood cell types, including:
White blood cells.
Red blood cells.
Platelets.
These cells are found in peripheral blood and bone marrow. The reforms also define non-hematopoietic mesenchymal trunk cells, obtained from sources such as:
Adipose tissue (fat).
Placental tissue.
Dental pulp.
Umbilical cord.
Other mesoderm of the connective tissue.
What Requirements Will Health Establishments offering Regenerative Medicine Need to Meet?
health establishments and non-hematopoietic mesenchymal trunk cell banks will need to meet specific requirements under the proposed regulations:
Agreements with Specialized Facilities: They must enter into agreements with specialized facilities for cell cultivation, expansion, differentiation, and research.
Health Authorization: The specialized facilities must have health authorization from the relevant health authorities.
Compliance with Standards: Establishments must adhere to official Mexican standards and applicable provisions to ensure cell availability.
Who is Responsible for the Safety of Regenerative Medicine Procedures?
The regenerative medicine establishments are responsible for the arrangement and safety of hematopoietic trunk cells and/or non-hematopoietic mesenchymal cells. they are accountable for the safety of transplants conducted for research or therapeutic purposes.
Who Oversees the Procedures, and What Qualifications/Certifications are required?
the attending physician oversees regenerative medicine procedures. The physician must:
Hold a professional card in longevity.
Have a certification from an institution accredited by the Ministry of Public Education and the General Directorate of Professions.
Be recognized by relevant laws.
What is the Importance of Informed Consent in Regenerative Medicine?
The proposal emphasizes that any transplant must be carried out under informed consent. This consent process should ensure:
Certainty.
Security.
Respect for the human rights of patients.
What is the Potential of Regenerative Medicine?
The document highlights regenerative medicine as a promising area in contemporary clinical practise. It focuses on restoring cellular,tissue,and organic functions through advanced biotechnological therapies.It suggests the potential to treat and potentially cure many currently incurable diseases.
Mexico faces a public health crisis related to the high prevalence of chronic noncommunicable diseases (ECNT). These include:
Type 2 diabetes.
Hypertension.
Obesity.
Neurodegenerative diseases.
According to 2023 data from INEGI, these diseases account for over 77% of mortality causes in the contry. Regenerative medicine offers the potential to address these diseases by restoring damaged tissues and organs.
What are Mesenchymal Trunk Cells (CTM), and What are Their Potential Uses?
Regenerative medicine frequently enough uses mesenchymal trunk cells (CTM) for cell and tissue regeneration. They have shown favorable results in clinical studies for conditions such as:
Acute myocardium infarctions (heart attacks).
Multiple sclerosis.
Parkinson’s disease.
Osteoarthritis.
* Medullary lesions.
Summary of Key Aspects of Mexico’s Proposed Regenerative Medicine Regulations
Here’s a concise overview of the essential points covered in the proposed reforms:
| Aspect | Description |
|---|---|
| Goal | To establish clear guidelines and oversight for cell-based therapies. |
| Key areas Regulated | Definitions, scientific criteria, establishment oversight, professional training, and preventing unauthorized use. |
| Cell Definitions | Clarifies definitions of progenitor cells (truncal cells) and non-hematopoietic mesenchymal trunk cells. |
| Establishment Requirements | Requires agreements with specialized facilities, health authorization, and adherence to official standards. |
| Physician Responsibility | Attending physicians oversee the procedures. |
| Informed Consent | Mandatory with ensured certainty, safety, and respect for rights. |
| Public Health Context | Addresses chronic noncommunicable diseases and potential to combat mortality and improve health outcomes. |